TMCI
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
Treace Medical Concepts, Inc. (TMCI) is scored daily on Deltasharpe Prism against Healthcare sector peers across five pillars: Value, Growth, Profitability, Momentum and Revisions.
Quantitative Factor Evaluation • Updated
Subscribe to unlock
Subscribe to unlock
Subscribe to unlock
Subscribe to unlock
Subscribe to unlock
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-15 | B- (3.0) | C- (1.9) | B- (3.0) | A- (3.9) | A+ (5.0) | B (3.4) |
| 2026-11-08 | B- (3.0) | C- (1.9) | B- (3.0) | B (3.2) | C+ (2.6) | C+ (2.8) |
| 2026-11-01 | B- (3.0) | C- (1.9) | B- (3.1) | B (3.4) | C+ (2.7) | C+ (2.8) |
| 2026-10-25 | B- (3.0) | C- (1.9) | B- (3.0) | B (3.5) | C+ (2.6) | C+ (2.8) |
Showing the last month only. Subscribe for the full factor score history.
For more — Subscribe